Aurinia Pharmaceuticals Inc. (FRA:IKAP)

Aurinia Pharmaceuticals Statistics

Total Valuation

FRA:IKAP has a market cap or net worth of EUR 1.83 billion. The enterprise value is 1.60 billion.

Market Cap	1.83B
Enterprise Value	1.60B

Important Dates

The next estimated earnings date is Thursday, February 26, 2026.

Earnings Date	Feb 26, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	131.84M
Shares Outstanding	n/a
Shares Change (YoY)	-1.24%
Shares Change (QoQ)	-1.10%
Owned by Insiders (%)	1.87%
Owned by Institutions (%)	54.46%
Float	128.25M

Valuation Ratios

The trailing PE ratio is 27.64 and the forward PE ratio is 19.02.

PE Ratio	27.64
Forward PE	19.02
PS Ratio	8.09
PB Ratio	5.88
P/TBV Ratio	5.95
P/FCF Ratio	17.98
P/OCF Ratio	17.91
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 18.34, with an EV/FCF ratio of 15.68.

EV / Earnings	24.10
EV / Sales	6.99
EV / EBITDA	18.34
EV / EBIT	22.92
EV / FCF	15.68

Financial Position

The company has a current ratio of 5.76, with a Debt / Equity ratio of 0.21.

Current Ratio	5.76
Quick Ratio	5.02
Debt / Equity	0.21
Debt / EBITDA	0.77
Debt / FCF	0.65
Interest Coverage	18.31

Financial Efficiency

Return on equity (ROE) is 20.65% and return on invested capital (ROIC) is 11.02%.

Return on Equity (ROE)	20.65%
Return on Assets (ROA)	9.41%
Return on Invested Capital (ROIC)	11.02%
Return on Capital Employed (ROCE)	17.97%
Revenue Per Employee	1.74M
Profits Per Employee	510,311
Employee Count	130
Asset Turnover	0.49
Inventory Turnover	1.26

Taxes

In the past 12 months, FRA:IKAP has paid 1.54 million in taxes.

Income Tax	1.54M
Effective Tax Rate	2.26%

Stock Price Statistics

The stock price has increased by +67.27% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+67.27%
50-Day Moving Average	11.32
200-Day Moving Average	8.75
Relative Strength Index (RSI)	71.02
Average Volume (20 Days)	8

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	4.78

Income Statement

In the last 12 months, FRA:IKAP had revenue of EUR 226.55 million and earned 66.34 million in profits. Earnings per share was 0.47.

Revenue	226.55M
Gross Profit	181.61M
Operating Income	69.12M
Pretax Income	67.88M
Net Income	66.34M
EBITDA	85.70M
EBIT	69.12M
Earnings Per Share (EPS)	0.47

Balance Sheet

The company has 299.59 million in cash and 66.66 million in debt, giving a net cash position of 232.93 million.

Cash & Cash Equivalents	299.59M
Total Debt	66.66M
Net Cash	232.93M
Net Cash Per Share	n/a
Equity (Book Value)	311.75M
Book Value Per Share	2.36
Working Capital	308.97M

Cash Flow

In the last 12 months, operating cash flow was 102.36 million and capital expenditures -392,910, giving a free cash flow of 101.97 million.

Operating Cash Flow	102.36M
Capital Expenditures	-392,910
Free Cash Flow	101.97M
FCF Per Share	n/a

Margins

Gross margin is 80.16%, with operating and profit margins of 30.51% and 29.28%.

Gross Margin	80.16%
Operating Margin	30.51%
Pretax Margin	29.96%
Profit Margin	29.28%
EBITDA Margin	37.83%
EBIT Margin	30.51%
FCF Margin	45.01%

Dividends & Yields

FRA:IKAP does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	1.24%
Shareholder Yield	1.24%
Earnings Yield	3.62%
FCF Yield	5.56%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

The last stock split was on October 23, 2013. It was a reverse split with a ratio of 0.02.

Last Split Date	Oct 23, 2013
Split Type	Reverse
Split Ratio	0.02

Scores

FRA:IKAP has an Altman Z-Score of 4.05 and a Piotroski F-Score of 6.

Altman Z-Score	4.05
Piotroski F-Score	6